GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 812 filers reported holding GLAXOSMITHKLINE PLC in Q4 2020. The put-call ratio across all filers is 1.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $6,574,000 | +41.4% | 151,027 | +41.5% | 0.14% | +69.0% |
| Q1 2022 | $4,649,000 | +2.5% | 106,734 | +3.8% | 0.08% | +6.3% |
| Q4 2021 | $4,534,000 | +7.0% | 102,816 | -7.3% | 0.08% | 0.0% |
| Q3 2021 | $4,237,000 | -0.9% | 110,891 | +3.3% | 0.08% | +2.6% |
| Q2 2021 | $4,274,000 | +15.1% | 107,335 | +3.2% | 0.08% | +4.1% |
| Q1 2021 | $3,713,000 | +5.1% | 104,012 | +8.3% | 0.07% | -1.3% |
| Q4 2020 | $3,534,000 | -6.0% | 96,038 | -3.9% | 0.08% | -20.2% |
| Q3 2020 | $3,760,000 | -9.7% | 99,901 | -2.2% | 0.09% | -13.0% |
| Q2 2020 | $4,166,000 | +32.8% | 102,135 | +23.3% | 0.11% | +13.7% |
| Q1 2020 | $3,138,000 | -9.3% | 82,832 | +12.5% | 0.10% | +10.5% |
| Q4 2019 | $3,460,000 | +14.2% | 73,623 | +3.7% | 0.09% | +3.6% |
| Q3 2019 | $3,029,000 | +4.8% | 70,966 | -1.7% | 0.08% | +5.1% |
| Q2 2019 | $2,889,000 | -17.2% | 72,195 | -13.6% | 0.08% | -15.1% |
| Q1 2019 | $3,491,000 | +9.0% | 83,542 | -0.4% | 0.09% | -7.0% |
| Q4 2018 | $3,204,000 | -21.7% | 83,846 | -17.7% | 0.10% | -3.8% |
| Q3 2018 | $4,090,000 | -1.4% | 101,836 | -1.0% | 0.10% | -8.0% |
| Q2 2018 | $4,147,000 | -9.3% | 102,860 | -12.1% | 0.11% | -3.4% |
| Q1 2018 | $4,573,000 | +72.4% | 117,040 | +56.5% | 0.12% | +72.1% |
| Q4 2017 | $2,652,000 | -29.4% | 74,802 | -19.1% | 0.07% | -32.7% |
| Q3 2017 | $3,755,000 | -13.8% | 92,491 | -8.4% | 0.10% | -15.8% |
| Q2 2017 | $4,356,000 | +4.8% | 101,027 | +2.5% | 0.12% | +1.7% |
| Q1 2017 | $4,155,000 | +13.5% | 98,549 | +3.7% | 0.12% | +10.3% |
| Q4 2016 | $3,660,000 | -13.9% | 95,030 | -3.6% | 0.11% | -13.7% |
| Q3 2016 | $4,253,000 | +3.6% | 98,603 | +4.1% | 0.12% | +1.6% |
| Q2 2016 | $4,104,000 | +4.5% | 94,718 | -2.2% | 0.12% | +2.5% |
| Q1 2016 | $3,928,000 | -12.7% | 96,880 | -13.2% | 0.12% | -11.2% |
| Q4 2015 | $4,502,000 | -9.1% | 111,562 | -13.4% | 0.13% | -10.7% |
| Q3 2015 | $4,953,000 | -8.0% | 128,788 | -0.4% | 0.15% | 0.0% |
| Q2 2015 | $5,386,000 | -23.2% | 129,311 | -14.9% | 0.15% | -21.5% |
| Q1 2015 | $7,013,000 | +64.0% | 151,951 | +51.9% | 0.19% | +55.3% |
| Q4 2014 | $4,275,000 | +32.1% | 100,055 | +42.2% | 0.12% | +28.1% |
| Q3 2014 | $3,235,000 | +21.8% | 70,364 | +41.7% | 0.10% | +20.0% |
| Q2 2014 | $2,656,000 | -8.4% | 49,668 | -8.4% | 0.08% | -8.0% |
| Q1 2014 | $2,898,000 | -4.1% | 54,246 | -4.2% | 0.09% | -10.3% |
| Q4 2013 | $3,023,000 | +8.1% | 56,606 | +1.5% | 0.10% | -1.0% |
| Q3 2013 | $2,797,000 | +16.3% | 55,752 | +15.8% | 0.10% | +5.4% |
| Q2 2013 | $2,406,000 | – | 48,129 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |